The role of aromatase inhibitors in the treatment of metastatic breast cancer

被引:23
作者
Mouridsen, H
Gershanovich, M
机构
[1] Rigshosp, Dept Oncol, Finsen Ctr, DK-2100 Copenhagen, Denmark
[2] NN Petrov Oncol Res Inst, Dept Clin Oncol, St Petersburg, Russia
关键词
D O I
10.1016/S0093-7754(03)00301-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:33 / 45
页数:13
相关论文
共 35 条
[1]   Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].
Bonneterre, J ;
Thürlimann, B ;
Robertson, JFR ;
Krzakowski, M ;
Mauriac, L ;
Koralewski, P ;
Vergote, I ;
Webster, A ;
Steinberg, M ;
von Euler, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757
[2]  
Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO
[3]  
2-Y
[4]  
Brueggemeier R W, 2001, Am J Ther, V8, P333, DOI 10.1097/00045391-200109000-00007
[5]   Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate [J].
Buzdar, A ;
Douma, J ;
Davidson, N ;
Elledge, R ;
Morgan, M ;
Smith, R ;
Porter, L ;
Nabholtz, J ;
Xiang, X ;
Brady, C .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3357-3366
[6]   Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: Results of overview analysis of two phase III trials [J].
Buzdar, A ;
Jonat, W ;
Howell, A ;
Jones, SE ;
Blomqvist, C ;
Vogel, CL ;
Eiermann, W ;
Wolter, JM ;
Azab, M ;
Webster, A ;
Plourde, PV .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) :2000-2011
[7]  
Buzdar AU, 1997, CANCER, V79, P730, DOI 10.1002/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO
[8]  
2-0
[9]  
Buzdar AU, 1998, CANCER-AM CANCER SOC, V83, P1142, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.3.CO
[10]  
2-7